Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can early therapy boost development in preterm babies?

NCT ID NCT03093337

Knowledge-focused Sponsor: University Hospital, Toulouse Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether early psychomotor therapy after hospital discharge helps very preterm infants (born between 24 and 30 weeks) develop better by age 2. The therapy involved 20 sessions between 2 and 9 months old, focusing on movement, sensory integration, and parent-child bonding. Researchers measured development using the Bayley Scales and also looked at parenting quality and therapy acceptance.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
psychomotor therapy sessions
What this could lead to
If successful, this could point toward a supportive therapy to improve development in very preterm infants.
What could go wrong
This is a completed study with 162 participants, but it is exploratory and may not show clear benefits. Results may not apply to all preterm infants.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

162 people

The number who actually took part.

Started

Dec 2007

Finished

Jul 2017

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

24 to 30 weeks

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Infants with a gestational age between 24 and 30 weeks. Exclusion Criteria: * Infants with congenital disease, * Infants with brain bleeding grade III-IV, * Infants with periventricular leucomalacia, * Infants whose mothers had a documented history of physical or mental illness, or drug abuse * Infants from non-French -speaking families.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Premature infant are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Cognitive Dysfunction Premature Birth

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Premature infant

Contacts and locations

Locations

  • CH Albi

    Albi, Midi-Pyrénées, 81013, France

  • CH Auch

    Auch, Midi-Pyrénées, 32008, France

  • CH Cahors

    Cahors, Midi-Pyrénées, 46005, France

  • CH Castres

    Castres, Midi-Pyrénées, 81108, France

  • CH Montauban

    Montauban, Midi-Pyrénées, 82013, France

  • CH Tarbes

    Tarbes, Midi-Pyrénées, 65013, France

  • CHIVA centre hospitalier du val d'Ariège

    Foix, Midi-Pyrénées, 09017, France

  • Clinique Ambroise Paré

    Toulouse, Midi-Pyrénées, 31082, France

  • Clinique Sarrus Teinturiers

    Toulouse, Midi-Pyrénées, 31076, France

  • Hôpital des enfants

    Toulouse, Midi-Pyrénées, 30159, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.